Activation of TRPV1 by capsaicin-ameliorated non-alcoholic fatty liver disease in mouse models [37], and TRPV1-mediated induction of PPARδ and UCP2 likely played a role in this effect [37]. Here, TRPV1 is linked to metabolic dysfunction-associated steatotic liver disease.